[go: up one dir, main page]

Gage et al., 2000 - Google Patents

Fluorescence determination of sulphobutylether-β-cyclodextrin in human plasma by size exclusion chromatography with inclusion complex formation

Gage et al., 2000

Document ID
5186052361024680528
Author
Gage R
Venn R
Bayliss M
Edgington A
Roffey S
Sorrell B
Publication year
Publication venue
Journal of pharmaceutical and biomedical analysis

External Links

Snippet

A selective method for the determination of sulphobutylether-β-cyclodextrin (SBECD) in human plasma has been developed and validated over the range 4–200 μg ml− 1. SBECD is extracted from plasma using end-capped cyclohexyl solid phase extraction cartridges …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins

Similar Documents

Publication Publication Date Title
Zaspel et al. Determination of alpha-tocopherol in tissues and plasma by high-performance liquid chromatography
Archontaki et al. Study on the inclusion complexes of bromazepam with β-and β-hydroxypropyl-cyclodextrins
KOIZUMI et al. Inclusion complexes of poorly water-soluble drugs with glucosyl-cyclodextrins
Carando et al. Comparison of (+)-catechin determination in human plasma by high-performance liquid chromatography with two types of detection: fluorescence and ultraviolet
Cheng et al. Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography
Cheng et al. A validated LC–MS/MS determination method for the illegal food additive rhodamine B: Applications of a pharmacokinetic study in rats
Gallego et al. Spectrophotometric determination of hydrocortisone, nystatin and oxytetracycline in synthetic and pharmaceutical preparations based on various univariate and multivariate methods
Dunnett et al. Reverse-phase ion-pairing high-performance liquid chromatography of phosphocreatine, creatine and creatinine in equine muscle
Sandall et al. Development and validation of an HPLC method for the determination of spironolactone and its metabolites in paediatric plasma samples
Zhang et al. Simultaneous determination and pharmacokinetic studies of dihydromyricetin and myricetin in rat plasma by HPLC-DAD after oral administration of Ampelopsis grossedentata decoction
Gage et al. Fluorescence determination of sulphobutylether-β-cyclodextrin in human plasma by size exclusion chromatography with inclusion complex formation
Bunch et al. A fast and simple assay for busulfan in serum or plasma by liquid chromatography–tandem mass spectrometry using turbulent flow online extraction technology
KR20130076892A (en) Highly sensitive method of determining the quantity of herbal medicine-derived components
Lesko et al. High‐pressure liquid chromatography of amiodarone in biological fluids
Bose et al. Amitriptyline and nortriptyline serum determination by micellar liquid chromatography
Brouwer et al. Linearized colorimetric assay for Cremophor EL: application to pharmacokinetics after 1-hour paclitaxel infusions
Saleh et al. Kinetic spectrophotometric determination of certain cephalosporins using oxidized quercetin reagent
Zaffaroni et al. High-performance liquid chromatographic assay for the determination of Aloe Emodin in mouse plasma
Cai et al. Simultaneous quantitation of etoposide and its catechol metabolite in human plasma using high-performance liquid chromatography with electrochemical detection
Jain et al. Simultaneous estimation of ofloxacin and tinidazole in solid dosage form by uv-spectrophotometry using mixed solvency concept
Mukker et al. HPLC method with fluorescence detection for the quantitative determination of flaxseed lignans
Bosáková et al. Study of the stability of promethazine enantiomers by liquid chromatography using a vancomycin-bonded chiral stationary phase
González-Peñas et al. A sensitive method for the determination of gemfibrozil in human plasma samples by RP-LC
Štěpánová et al. Separation of rotamers of 5-nitrosopyrimidines and estimation of binding constants of their complexes with β-cyclodextrin by capillary electrophoresis
Ahmad et al. Development and validation of RP-HPLC method for simultaneous estimation of glibenclamide and thymoquinone in rat plasma and its application to pharmacokinetics